Developing countries in Southeast Asia, Africa, and the Americas are now the new front in an increasingly contentious struggle between Asia’s two continental powers. India and China, both pharmaceutical manufacturing powerhouses, are jostling over who will become the primary supplier of COVID-19 vaccines to many of the world’s poorest countries.
The Serum Institute of India (SII), the world’s largest vaccine manufacturer, is producing vaccines in collaboration with the University of Oxford and AstraZeneca, and in just the past few days the company’s shipped tens of millions of doses to Bhutan, Nepal, Bangladesh, Maldives, Myanmar, Mauritius, and Seychelles.
Lead the Conversation on China
Subscribe Today to Get Full Access to The China-Global South Project
The China-Global South Daily Brief delivered to your inbox at 6AM Washington time
Full access to exclusive news and analysis from editors based in the Global South
Transcripts of CGSP’s twice-weekly podcasts